MarketMoversReport

MediWound Announces Positive Results

Long
NASDAQ:MDWD   MediWound Ltd.
MDWD: MediWound Ltd.
2022-07-07 07:00:00
MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.